Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) Sees Large Decline in Short Interest
by Amy Steele · The Cerbat GemShin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF – Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 15th, there was short interest totaling 15,500 shares, adecreaseof27.2% from the July 31st total of 21,300 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.
Shin Nippon Biomedical Laboratories Stock Performance
Shin Nippon Biomedical Laboratories stock opened at $9.36 on Tuesday. The firm’s 50 day moving average price is $9.36 and its two-hundred day moving average price is $9.43. Shin Nippon Biomedical Laboratories has a twelve month low of $9.36 and a twelve month high of $9.51.
Shin Nippon Biomedical Laboratories Company Profile
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally. It offers non-clinical studies, including single/repeated dose toxicity studies, antigenicity studies, skin sensitization studies, genotoxicity studies, carcinogenicity studies, local irritation studies, inhalation toxicity studies, TK studies, characteristic studies, stability studies, dependence studies, reproductive and developmental toxicity studies, safety pharmacological studies, and pharmacokinetic studies.
See Also
- Five stocks we like better than Shin Nippon Biomedical Laboratories
- Following Congress Stock Trades
- Why These Banking Stocks Could Soar on Rate Cuts
- What Is WallStreetBets and What Stocks Are They Targeting?
- 3 Big Dividend Hikes Hit the Market—1 Just Doubled Its Payout
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- What NVIDIA’s Big Bet on Rival Quantinuum Means for D-Wave Stock